Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,204
archived clinical trials in
Healthy Studies

The Effect of Processing on the Measured Energy Value of Almonds in the Human Diet
Macronutrient Absorption From Almonds: The Effect of Processing on the Measured Energy Value of Almonds in the Human Diet
Status: Enrolling
Updated:  1/13/2014
USDA Beltsville Human Nutrition Research Center
mi
from
Beltsville, MD
The Effect of Processing on the Measured Energy Value of Almonds in the Human Diet
Macronutrient Absorption From Almonds: The Effect of Processing on the Measured Energy Value of Almonds in the Human Diet
Status: Enrolling
Updated: 1/13/2014
USDA Beltsville Human Nutrition Research Center
mi
from
Beltsville, MD
Click here to add this to my saved trials
A Phase I Study in Healthy Volunteers to Assess the Effect of Cytochrome3A4 (CYP3A4) Inhibitors (Diltiazem and Itraconazole) on the Pharmacokinetics (PK) of AZD3293 and the Effects of AZD3293 on the Pharmacokinetics of Midazolam, a Cytochrome 3A4 and Cytochrome 3A5 (CYP3A4/CYP3A5) Substrate
A Phase I, Single-center, Open-label, 3-group, Fixed-sequence Study to Assess the Effect of Itraconazole, a Potent CYP3A4 Inhibitor, or Diltiazem, a Moderate CYP3A4 Inhibitor, on the Pharmacokinetics of AZD3293 and the Effects of AZD3293 on the Pharmacokinetics of Midazolam, a CYP3A4/CYP3A5 Substrate, in Healthy Young Male and Female Volunteers
Status: Enrolling
Updated:  1/14/2014
Clinical Research Facility
mi
from
Cypress, CA
A Phase I Study in Healthy Volunteers to Assess the Effect of Cytochrome3A4 (CYP3A4) Inhibitors (Diltiazem and Itraconazole) on the Pharmacokinetics (PK) of AZD3293 and the Effects of AZD3293 on the Pharmacokinetics of Midazolam, a Cytochrome 3A4 and Cytochrome 3A5 (CYP3A4/CYP3A5) Substrate
A Phase I, Single-center, Open-label, 3-group, Fixed-sequence Study to Assess the Effect of Itraconazole, a Potent CYP3A4 Inhibitor, or Diltiazem, a Moderate CYP3A4 Inhibitor, on the Pharmacokinetics of AZD3293 and the Effects of AZD3293 on the Pharmacokinetics of Midazolam, a CYP3A4/CYP3A5 Substrate, in Healthy Young Male and Female Volunteers
Status: Enrolling
Updated: 1/14/2014
Clinical Research Facility
mi
from
Cypress, CA
Click here to add this to my saved trials
Circadian Phase Assessments at Home
Status: Enrolling
Updated:  1/15/2014
Rush University Medical Center
mi
from
Chicago, IL
Circadian Phase Assessments at Home
Status: Enrolling
Updated: 1/15/2014
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Study Of PF-06410293 And Adalimumab In Healthy Subjects (REFLECTIONS B538-01)
Phase 1, Double Blind, Randomized, Parallel-Group, Single-Dose, 3-Arm, Comparative Pharmacokinetic Study Of PF-06410293 and Adalimumab Sourced From US And EU Administered To Healthy Subjects
Status: Enrolling
Updated:  1/15/2014
Pfizer Investigational Site
mi
from
New Haven, CT
Study Of PF-06410293 And Adalimumab In Healthy Subjects (REFLECTIONS B538-01)
Phase 1, Double Blind, Randomized, Parallel-Group, Single-Dose, 3-Arm, Comparative Pharmacokinetic Study Of PF-06410293 and Adalimumab Sourced From US And EU Administered To Healthy Subjects
Status: Enrolling
Updated: 1/15/2014
Pfizer Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
Bioavailability of Lesinurad and Intravenous [14C]Lesinurad
A Phase 1, Open-Label Study to Assess the Absolute Bioavailability of a Single Oral Dose of Lesinurad With Respect to an Intravenous Micro Tracer Dose of [14C]Lesinurad in Healthy Adult Male Subjects
Status: Enrolling
Updated:  1/16/2014
Clinical Research Facility
mi
from
Madison, WI
Bioavailability of Lesinurad and Intravenous [14C]Lesinurad
A Phase 1, Open-Label Study to Assess the Absolute Bioavailability of a Single Oral Dose of Lesinurad With Respect to an Intravenous Micro Tracer Dose of [14C]Lesinurad in Healthy Adult Male Subjects
Status: Enrolling
Updated: 1/16/2014
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Activity, Gait, and Efficacy (AGE II): Functional Limitations and Quality of Life
Activity, Gait, and Efficacy (AGE II): Functional Limitations and Quality of Life
Status: Enrolling
Updated:  1/23/2014
University of Illinois at Urbana-Champaign
mi
from
Urbana, IL
Activity, Gait, and Efficacy (AGE II): Functional Limitations and Quality of Life
Activity, Gait, and Efficacy (AGE II): Functional Limitations and Quality of Life
Status: Enrolling
Updated: 1/23/2014
University of Illinois at Urbana-Champaign
mi
from
Urbana, IL
Click here to add this to my saved trials
CC100: Safety and Tolerability of Single Doses
Protocol CC100A CC100: Safety and Tolerability of Single Doses
Status: Enrolling
Updated:  1/29/2014
IU Health Neuroscience Center
mi
from
Indianapolis, IN
CC100: Safety and Tolerability of Single Doses
Protocol CC100A CC100: Safety and Tolerability of Single Doses
Status: Enrolling
Updated: 1/29/2014
IU Health Neuroscience Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Pharmacokinetics of a Fixed Dose Combination of Canagliflozin/Metformin Coadministered With Food
A Single-Dose, Open-Label, Randomized, 2-Period Crossover Study to Assess the Effect of Food Coadministration on the Pharmacokinetics of a Fixed Dose Combination Tablet of Canagliflozin (JNJ-28431754) and Metformin Extended Release in Healthy Subjects
Status: Enrolling
Updated:  2/3/2014
Clinical Research Facility
mi
from
Lincoln, NE
Pharmacokinetics of a Fixed Dose Combination of Canagliflozin/Metformin Coadministered With Food
A Single-Dose, Open-Label, Randomized, 2-Period Crossover Study to Assess the Effect of Food Coadministration on the Pharmacokinetics of a Fixed Dose Combination Tablet of Canagliflozin (JNJ-28431754) and Metformin Extended Release in Healthy Subjects
Status: Enrolling
Updated: 2/3/2014
Clinical Research Facility
mi
from
Lincoln, NE
Click here to add this to my saved trials
Study to Assess the Pharmacokinetics of Cabozantinib (XL184) in Hepatic Impaired Adult Subjects
A Phase I, Open-Label, Parallel-Group, Single-Dose Study to Assess the Pharmacokinetics of XL184 (Cabozantinib) Capsules in Hepatic Impaired Adult Subjects
Status: Enrolling
Updated:  2/10/2014
Mcguire Va Medical Center
mi
from
Richmond, VA
Study to Assess the Pharmacokinetics of Cabozantinib (XL184) in Hepatic Impaired Adult Subjects
A Phase I, Open-Label, Parallel-Group, Single-Dose Study to Assess the Pharmacokinetics of XL184 (Cabozantinib) Capsules in Hepatic Impaired Adult Subjects
Status: Enrolling
Updated: 2/10/2014
Mcguire Va Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Relative Bioavailability Study to Assess Two Solid Formulations Compared to an Oral Solution of AZD3293 in Healthy Male and Non-Fertile Female Subjects
A Phase 1, Open-label, Randomized, Single-dose, 3-period Cross-over, Relative Bioavailability Study to Assess Two Solid Formulations Compared to an Oral Solution of AZD3293 in Healthy Male and Non-Fertile Female Subjects
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Cypress, CA
Relative Bioavailability Study to Assess Two Solid Formulations Compared to an Oral Solution of AZD3293 in Healthy Male and Non-Fertile Female Subjects
A Phase 1, Open-label, Randomized, Single-dose, 3-period Cross-over, Relative Bioavailability Study to Assess Two Solid Formulations Compared to an Oral Solution of AZD3293 in Healthy Male and Non-Fertile Female Subjects
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Cypress, CA
Click here to add this to my saved trials
Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786)
Status: Enrolling
Updated:  2/11/2014
Clinical Research Facility
mi
from
Gainesville, FL
Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786)
Status: Enrolling
Updated: 2/11/2014
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786)
Status: Enrolling
Updated:  2/11/2014
Clinical Research Facility
mi
from
Orlando, FL
Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786)
Status: Enrolling
Updated: 2/11/2014
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786)
Status: Enrolling
Updated:  2/11/2014
Clinical Research Facility
mi
from
Boston, MA
Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786)
Status: Enrolling
Updated: 2/11/2014
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786)
Status: Enrolling
Updated:  2/11/2014
Clinical Research Facility
mi
from
St. Louis, MO
Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786)
Status: Enrolling
Updated: 2/11/2014
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786)
Status: Enrolling
Updated:  2/11/2014
Clinical Research Facility
mi
from
Athens, OH
Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786)
Status: Enrolling
Updated: 2/11/2014
Clinical Research Facility
mi
from
Athens, OH
Click here to add this to my saved trials
Multiple Dose Pharmacokinetics of Canagliflozin/Metformin 150/1,000 mg Fixed Dose Combination
An Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics of Canagliflozin (JNJ-28431754) and Metformin Following Once-Daily Administration of 2 Canagliflozin/Metformin XR (150/1,000-mg) Fixed Dose Combination Tablets in Healthy Subjects
Status: Enrolling
Updated:  2/17/2014
Clinical Research Facility
mi
from
Neptune, NJ
Multiple Dose Pharmacokinetics of Canagliflozin/Metformin 150/1,000 mg Fixed Dose Combination
An Open-Label Study to Evaluate the Multiple Dose Pharmacokinetics of Canagliflozin (JNJ-28431754) and Metformin Following Once-Daily Administration of 2 Canagliflozin/Metformin XR (150/1,000-mg) Fixed Dose Combination Tablets in Healthy Subjects
Status: Enrolling
Updated: 2/17/2014
Clinical Research Facility
mi
from
Neptune, NJ
Click here to add this to my saved trials
Phosphorous Magnetic Resonance Spectroscopy of Heart
31P Magnetic Resonance Spectroscopy of Heart
Status: Enrolling
Updated:  2/18/2014
Washington University, St. Louis
mi
from
St. Louis, MO
Phosphorous Magnetic Resonance Spectroscopy of Heart
31P Magnetic Resonance Spectroscopy of Heart
Status: Enrolling
Updated: 2/18/2014
Washington University, St. Louis
mi
from
St. Louis, MO
Click here to add this to my saved trials
Phosphorous Magnetic Resonance Spectroscopy of Heart
31P Magnetic Resonance Spectroscopy of Heart
Status: Enrolling
Updated:  2/18/2014
Washington University, St. Louis
mi
from
St. Louis, MO
Phosphorous Magnetic Resonance Spectroscopy of Heart
31P Magnetic Resonance Spectroscopy of Heart
Status: Enrolling
Updated: 2/18/2014
Washington University, St. Louis
mi
from
St. Louis, MO
Click here to add this to my saved trials
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Status: Enrolling
Updated:  2/20/2014
University of California at San Diego
mi
from
San Diego, CA
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Status: Enrolling
Updated: 2/20/2014
University of California at San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Status: Enrolling
Updated:  2/20/2014
University of California - San Francisco
mi
from
San Francisco, CA
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Status: Enrolling
Updated: 2/20/2014
University of California - San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Status: Enrolling
Updated:  2/20/2014
Stanford University School of Medicine
mi
from
Stanford, CA
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Status: Enrolling
Updated: 2/20/2014
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Status: Enrolling
Updated:  2/20/2014
Children's Memorial Hospital Division of Dermatology
mi
from
Chicago, IL
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Status: Enrolling
Updated: 2/20/2014
Children's Memorial Hospital Division of Dermatology
mi
from
Chicago, IL
Click here to add this to my saved trials
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Status: Enrolling
Updated:  2/20/2014
UMass Memorial Dermatology Center
mi
from
Worcester, MA
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Status: Enrolling
Updated: 2/20/2014
UMass Memorial Dermatology Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Status: Enrolling
Updated:  2/20/2014
Central Dermatology
mi
from
St. Louis, MO
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Status: Enrolling
Updated: 2/20/2014
Central Dermatology
mi
from
St. Louis, MO
Click here to add this to my saved trials
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Status: Enrolling
Updated:  2/20/2014
University Hospitals, Case Medical Centers
mi
from
Cleveland, OH
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Status: Enrolling
Updated: 2/20/2014
University Hospitals, Case Medical Centers
mi
from
Cleveland, OH
Click here to add this to my saved trials
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Status: Enrolling
Updated:  2/20/2014
Texas Dermatology Associates
mi
from
Dallas, TX
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Status: Enrolling
Updated: 2/20/2014
Texas Dermatology Associates
mi
from
Dallas, TX
Click here to add this to my saved trials
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Status: Enrolling
Updated:  2/20/2014
Texas Children's Hospital
mi
from
Houston, TX
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Status: Enrolling
Updated: 2/20/2014
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
A Study To Observe Safety And Blood Concentrations Of PF-06412562 During And Following The Oral Administration Of Multiple Doses Of PF-06412562 In Healthy Adult Volunteers
Phase 1, Double Blind, Sponsor Open, Randomized, Placebo Controlled, Dose Escalation, Parallel Group Study To Investigate The Safety, Tolerability And Pharmacokinetics Of Repeat Doses Of PF-06412562 In Healthy Subjects
Status: Enrolling
Updated:  2/25/2014
Pfizer Investigational Site
mi
from
New Haven, CT
A Study To Observe Safety And Blood Concentrations Of PF-06412562 During And Following The Oral Administration Of Multiple Doses Of PF-06412562 In Healthy Adult Volunteers
Phase 1, Double Blind, Sponsor Open, Randomized, Placebo Controlled, Dose Escalation, Parallel Group Study To Investigate The Safety, Tolerability And Pharmacokinetics Of Repeat Doses Of PF-06412562 In Healthy Subjects
Status: Enrolling
Updated: 2/25/2014
Pfizer Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
CDC Anthrax Vaccine Clinical Trial
Anthrax Vaccine Adsorbed: Human Reactogenicity and Immunogenicity Trial to Address Change in Route of Administration and Dose Reduction
Status: Enrolling
Updated:  2/25/2014
Dr Scott Parker
mi
from
Birmingham, AL
CDC Anthrax Vaccine Clinical Trial
Anthrax Vaccine Adsorbed: Human Reactogenicity and Immunogenicity Trial to Address Change in Route of Administration and Dose Reduction
Status: Enrolling
Updated: 2/25/2014
Dr Scott Parker
mi
from
Birmingham, AL
Click here to add this to my saved trials
CDC Anthrax Vaccine Clinical Trial
Anthrax Vaccine Adsorbed: Human Reactogenicity and Immunogenicity Trial to Address Change in Route of Administration and Dose Reduction
Status: Enrolling
Updated:  2/25/2014
Dr. Harry Keyserling
mi
from
Atlanta, GA
CDC Anthrax Vaccine Clinical Trial
Anthrax Vaccine Adsorbed: Human Reactogenicity and Immunogenicity Trial to Address Change in Route of Administration and Dose Reduction
Status: Enrolling
Updated: 2/25/2014
Dr. Harry Keyserling
mi
from
Atlanta, GA
Click here to add this to my saved trials
CDC Anthrax Vaccine Clinical Trial
Anthrax Vaccine Adsorbed: Human Reactogenicity and Immunogenicity Trial to Address Change in Route of Administration and Dose Reduction
Status: Enrolling
Updated:  2/25/2014
Dr Janiine Babcock
mi
from
Silver Spring, MD
CDC Anthrax Vaccine Clinical Trial
Anthrax Vaccine Adsorbed: Human Reactogenicity and Immunogenicity Trial to Address Change in Route of Administration and Dose Reduction
Status: Enrolling
Updated: 2/25/2014
Dr Janiine Babcock
mi
from
Silver Spring, MD
Click here to add this to my saved trials
CDC Anthrax Vaccine Clinical Trial
Anthrax Vaccine Adsorbed: Human Reactogenicity and Immunogenicity Trial to Address Change in Route of Administration and Dose Reduction
Status: Enrolling
Updated:  2/25/2014
Dr. Gregory Poland
mi
from
Rochester, MN
CDC Anthrax Vaccine Clinical Trial
Anthrax Vaccine Adsorbed: Human Reactogenicity and Immunogenicity Trial to Address Change in Route of Administration and Dose Reduction
Status: Enrolling
Updated: 2/25/2014
Dr. Gregory Poland
mi
from
Rochester, MN
Click here to add this to my saved trials
CDC Anthrax Vaccine Clinical Trial
Anthrax Vaccine Adsorbed: Human Reactogenicity and Immunogenicity Trial to Address Change in Route of Administration and Dose Reduction
Status: Enrolling
Updated:  2/25/2014
Dr. Wendy Keitel
mi
from
Houston, TX
CDC Anthrax Vaccine Clinical Trial
Anthrax Vaccine Adsorbed: Human Reactogenicity and Immunogenicity Trial to Address Change in Route of Administration and Dose Reduction
Status: Enrolling
Updated: 2/25/2014
Dr. Wendy Keitel
mi
from
Houston, TX
Click here to add this to my saved trials
A Drug Interaction Study Between Bosutinib And Aprepitant In Healthy Volunteers
An Open-Label, Randomized, 2-Period Crossover Study To Evaluate The Effect Of A Single Dose Of Aprepitant, A Moderate CYP3A Inhibitor On Bosutinib Administered Orally To Healthy Subjects
Status: Enrolling
Updated:  3/2/2014
Pfizer Investigational Site
mi
from
New Haven, CT
A Drug Interaction Study Between Bosutinib And Aprepitant In Healthy Volunteers
An Open-Label, Randomized, 2-Period Crossover Study To Evaluate The Effect Of A Single Dose Of Aprepitant, A Moderate CYP3A Inhibitor On Bosutinib Administered Orally To Healthy Subjects
Status: Enrolling
Updated: 3/2/2014
Pfizer Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
COMIDAS Comparing Original Mexican Diets and Standard US Diets
Metabolic Response to Western vs. Indigenous Diets in Hispanic Women
Status: Enrolling
Updated:  3/4/2014
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
COMIDAS Comparing Original Mexican Diets and Standard US Diets
Metabolic Response to Western vs. Indigenous Diets in Hispanic Women
Status: Enrolling
Updated: 3/4/2014
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Single Dose Safety, Tolerability and Pharmacokinetic Study of NCTX in Healthy Volunteers
Phase 1 Single Dose, Double-blind, Dose-escalation, Safety, Tolerability and Pharmacokinetic Study of NCTX (PEGylated Liposomal Iodixanol Injection) in Healthy Volunteers
Status: Enrolling
Updated:  3/6/2014
Quintiles Phase 1 Services
mi
from
Overland Park, KA
Single Dose Safety, Tolerability and Pharmacokinetic Study of NCTX in Healthy Volunteers
Phase 1 Single Dose, Double-blind, Dose-escalation, Safety, Tolerability and Pharmacokinetic Study of NCTX (PEGylated Liposomal Iodixanol Injection) in Healthy Volunteers
Status: Enrolling
Updated: 3/6/2014
Quintiles Phase 1 Services
mi
from
Overland Park, KA
Click here to add this to my saved trials
Study Evaluating the Digestibility of Serum-Derived Bovine Immunoglobulin Protein Isolate in Healthy Adults
A Randomized, Crossover Clinical Study Evaluating the Digestibility of Serum-Derived Bovine Immunoglobulin Protein Isolate (SBI) in Healthy Adults
Status: Enrolling
Updated:  3/10/2014
PMG Research of Cary
mi
from
Cary, NC
Study Evaluating the Digestibility of Serum-Derived Bovine Immunoglobulin Protein Isolate in Healthy Adults
A Randomized, Crossover Clinical Study Evaluating the Digestibility of Serum-Derived Bovine Immunoglobulin Protein Isolate (SBI) in Healthy Adults
Status: Enrolling
Updated: 3/10/2014
PMG Research of Cary
mi
from
Cary, NC
Click here to add this to my saved trials
Study Evaluating the Digestibility of Serum-Derived Bovine Immunoglobulin Protein Isolate in Healthy Adults
A Randomized, Crossover Clinical Study Evaluating the Digestibility of Serum-Derived Bovine Immunoglobulin Protein Isolate (SBI) in Healthy Adults
Status: Enrolling
Updated:  3/10/2014
Wake Research Associates, LLC
mi
from
Raleigh, NC
Study Evaluating the Digestibility of Serum-Derived Bovine Immunoglobulin Protein Isolate in Healthy Adults
A Randomized, Crossover Clinical Study Evaluating the Digestibility of Serum-Derived Bovine Immunoglobulin Protein Isolate (SBI) in Healthy Adults
Status: Enrolling
Updated: 3/10/2014
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study to Assess the Relative Bioavailability of 7 Test Tablet Formulations of JNJ-56021927 With Respect to the Capsule Formulation of JNJ-56021927 in Healthy Male Participants
A Single-Dose, Open-Label, Randomized, Parallel-Group Study to Assess the Relative Bioavailability of 7 Test Tablet Formulations of JNJ-56021927 With Respect to the Capsule Formulation of JNJ-56021927 Under Fasted Conditions in Healthy Male Subjects
Status: Enrolling
Updated:  3/11/2014
Clinical Research Facility
mi
from
Tempe, AZ
A Study to Assess the Relative Bioavailability of 7 Test Tablet Formulations of JNJ-56021927 With Respect to the Capsule Formulation of JNJ-56021927 in Healthy Male Participants
A Single-Dose, Open-Label, Randomized, Parallel-Group Study to Assess the Relative Bioavailability of 7 Test Tablet Formulations of JNJ-56021927 With Respect to the Capsule Formulation of JNJ-56021927 Under Fasted Conditions in Healthy Male Subjects
Status: Enrolling
Updated: 3/11/2014
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
Alternative 10 mg/mL Liquid Formulation of ACY 1215 (Ricolinostat) in Healthy Subjects
Open-Label, Randomized, Single Dose, 3-Period Crossover to Evaluate the Relative Bioavailability and Food-Effect on Pharmacokinetics of Alternative 10 mg/mL Liquid Formulation ACY-1215 (Ricolinostat) in Healthy Subjects
Status: Enrolling
Updated:  3/13/2014
Covance Clinical Research Unit Incorporated
mi
from
Madison, WI
Alternative 10 mg/mL Liquid Formulation of ACY 1215 (Ricolinostat) in Healthy Subjects
Open-Label, Randomized, Single Dose, 3-Period Crossover to Evaluate the Relative Bioavailability and Food-Effect on Pharmacokinetics of Alternative 10 mg/mL Liquid Formulation ACY-1215 (Ricolinostat) in Healthy Subjects
Status: Enrolling
Updated: 3/13/2014
Covance Clinical Research Unit Incorporated
mi
from
Madison, WI
Click here to add this to my saved trials
Training in the Workplace
Training in the Workplace
Status: Enrolling
Updated:  3/18/2014
Massachusettts General Hospital
mi
from
Boston, MA
Training in the Workplace
Training in the Workplace
Status: Enrolling
Updated: 3/18/2014
Massachusettts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Make Better Choices
Make Better Choices (MBC) - Multiple Behavior Change in Diet and Activity
Status: Enrolling
Updated:  3/19/2014
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Make Better Choices
Make Better Choices (MBC) - Multiple Behavior Change in Diet and Activity
Status: Enrolling
Updated: 3/19/2014
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo
A Multi-Center, Randomized, Double-Blind, Parallel-Group Study Evaluating The Sexual Functioning of Healthy Adults After Receiving Multiple-Dose Regimens of Vilazodone, Paroxetine, or Placebo
Status: Enrolling
Updated:  3/25/2014
Forest Investigative site 067
mi
from
Miami, FL
Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo
A Multi-Center, Randomized, Double-Blind, Parallel-Group Study Evaluating The Sexual Functioning of Healthy Adults After Receiving Multiple-Dose Regimens of Vilazodone, Paroxetine, or Placebo
Status: Enrolling
Updated: 3/25/2014
Forest Investigative site 067
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo
A Multi-Center, Randomized, Double-Blind, Parallel-Group Study Evaluating The Sexual Functioning of Healthy Adults After Receiving Multiple-Dose Regimens of Vilazodone, Paroxetine, or Placebo
Status: Enrolling
Updated:  3/25/2014
Forest Investigative Site 004
mi
from
Overland Park, KA
Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo
A Multi-Center, Randomized, Double-Blind, Parallel-Group Study Evaluating The Sexual Functioning of Healthy Adults After Receiving Multiple-Dose Regimens of Vilazodone, Paroxetine, or Placebo
Status: Enrolling
Updated: 3/25/2014
Forest Investigative Site 004
mi
from
Overland Park, KA
Click here to add this to my saved trials
Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo
A Multi-Center, Randomized, Double-Blind, Parallel-Group Study Evaluating The Sexual Functioning of Healthy Adults After Receiving Multiple-Dose Regimens of Vilazodone, Paroxetine, or Placebo
Status: Enrolling
Updated:  3/25/2014
Forest Investigative site 011
mi
from
St. Paul, MN
Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo
A Multi-Center, Randomized, Double-Blind, Parallel-Group Study Evaluating The Sexual Functioning of Healthy Adults After Receiving Multiple-Dose Regimens of Vilazodone, Paroxetine, or Placebo
Status: Enrolling
Updated: 3/25/2014
Forest Investigative site 011
mi
from
St. Paul, MN
Click here to add this to my saved trials
Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo
A Multi-Center, Randomized, Double-Blind, Parallel-Group Study Evaluating The Sexual Functioning of Healthy Adults After Receiving Multiple-Dose Regimens of Vilazodone, Paroxetine, or Placebo
Status: Enrolling
Updated:  3/25/2014
Forest Investigative Site 064
mi
from
Charlottesville, VA
Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo
A Multi-Center, Randomized, Double-Blind, Parallel-Group Study Evaluating The Sexual Functioning of Healthy Adults After Receiving Multiple-Dose Regimens of Vilazodone, Paroxetine, or Placebo
Status: Enrolling
Updated: 3/25/2014
Forest Investigative Site 064
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Role of the Laser Pointer in Budgeting Fluoroscopy Time and Radiation Exposure
Role of the Laser Pointer in Budgeting Fluoroscopy Time and Radiation Exposure
Status: Enrolling
Updated:  3/31/2014
UF and Shands Orthopaedics and Sports Medicine Institute
mi
from
Gainesville, FL
Role of the Laser Pointer in Budgeting Fluoroscopy Time and Radiation Exposure
Role of the Laser Pointer in Budgeting Fluoroscopy Time and Radiation Exposure
Status: Enrolling
Updated: 3/31/2014
UF and Shands Orthopaedics and Sports Medicine Institute
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants
A Single-Dose, Open-Label, Randomized, 3-Way Crossover Pivotal Study to Assess the Bioequivalence of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) (2 x 150 mg/500 mg) With Respect to the Individual Components of Canagliflozin (1 x 300 mg) and Metformin XR Tablet (2 x 500 mg) in Healthy Fed Subjects
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Tempe, AZ
A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants
A Single-Dose, Open-Label, Randomized, 3-Way Crossover Pivotal Study to Assess the Bioequivalence of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) (2 x 150 mg/500 mg) With Respect to the Individual Components of Canagliflozin (1 x 300 mg) and Metformin XR Tablet (2 x 500 mg) in Healthy Fed Subjects
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
A First Time in Man Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1979 in Healthy Males
A Phase I, Single-center, Single-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral AZD1979 After Single-ascending Doses in Healthy Male Volunteers
Status: Enrolling
Updated:  4/2/2014
Clinical Research Facility
mi
from
Overland Park, KA
A First Time in Man Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1979 in Healthy Males
A Phase I, Single-center, Single-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral AZD1979 After Single-ascending Doses in Healthy Male Volunteers
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
Bioequivalence of Two Transdermal Clonidine Administrations in Healthy Volunteers
A Randomized, Double-blind Study Designed to Assess the Bioequivalence and Adhesion Properties of Transdermal Clonidine-VistanexTM Compared to Transdermal Clonidine-Oppanol® Following Transdermal Administration in Healthy Male and Female Volunteers
Status: Enrolling
Updated:  4/2/2014
Boehringer Ingelheim Investigational Site
mi
from
Austin, TX
Bioequivalence of Two Transdermal Clonidine Administrations in Healthy Volunteers
A Randomized, Double-blind Study Designed to Assess the Bioequivalence and Adhesion Properties of Transdermal Clonidine-VistanexTM Compared to Transdermal Clonidine-Oppanol® Following Transdermal Administration in Healthy Male and Female Volunteers
Status: Enrolling
Updated: 4/2/2014
Boehringer Ingelheim Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials